Black Diamond Therapeutics Inc. (NASDAQ: BDTX)
$2.1500
-0.0400 ( +0.47% ) 287.8K
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Market Data
Open
$2.1500
Previous close
$2.1900
Volume
287.8K
Market cap
$125.34M
Day range
$2.1050 - $2.3640
52 week range
$2.1050 - $7.6600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
10-q | Quarterly Reports | 64 | May 09, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
def | Proxies and info statements | 4 | Apr 24, 2024 |
ars | Annual reports | 1 | Apr 24, 2024 |
3 | Insider transactions | 2 | Apr 12, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |